Peripheral purinergic receptor modulation influences the trigeminal ganglia nitroxidergic system in an experimental murine model of inflammatory orofacial pain

Journal of Neuroscience Research

Volumn 88, Issue 12, 2010, Pages 2715-2726

  Borsani, Elisa ^a   Albertini, Roberta ^a   Labanca, Mauro ^a,b   Lonati, Claudio ^a   Rezzani, Rita ^a   Rodella, Luigi F ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Inflammatory pain; Mice; Nitroxidergic system; Purinergic receptors; Trigeminal system

Indexed keywords

5 [[(3 PHENOXYBENZYL)(1,2,3,4 TETRAHYDRO 1 NAPHTHYL)AMINO]CARBONYL]TRIMELLITIC ACID; FORMALDEHYDE; NITRIC OXIDE SYNTHASE; PROTEIN FOS; PURINERGIC RECEPTOR; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN STEM; CONTROLLED STUDY; FACE PAIN; INFLAMMATORY OROFACIAL PAIN; INJECTION; MALE; MOUSE; NERVE CELL; NEUROMODULATION; NEUROTRANSMISSION; NITRERGIC NERVE; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIGEMINUS GANGLION;

ANIMALS; DISEASE MODELS, ANIMAL; FACIAL PAIN; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; NITRERGIC NEURONS; NITRIC OXIDE; NOCICEPTORS; RECEPTORS, PURINERGIC P2X2; RECEPTORS, PURINERGIC P2X3; TRIGEMINAL GANGLION;

EID: 77955491309     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22420     Document Type: Article

References (60)

1. Andoh T, Kuraishi Y. 2004. Expression of Fc epsilon receptor I on primary sensory neurons in mice. Neuroreport 15:2029-2031.
2. Arvidsson J, Gobel S. 1981. An HRP study of the central projections of primary trigeminal neurons which innervate tooth pulps in the cat. Brain Res 210:1-16.
3. Baader SL, Schilling K. 1996. Glutamate receptors mediate dynamic regulation of nitric oxide synthase expression in cerebellar granule cells. J Neurosci 16:1440-1449.
4. Baltrons MA, García A. 1997. AMPA receptors are coupled to the nitric oxide/cyclic GMP pathway in cerebellar astroglial cells. Eur J Neurosci 9:2497-2501. (Pubitemid 28006002)
5. Boettger MK, Üceyler N, Zelenka M, Schmitt A, Reif A, Chen Y, Sommer C. 2007. Differences in inflammatory pain in nNOS-, iNOS-and eNOS-deficient mice. Eur J Pain 11:810-818.
6. Borsani E, Albertini R, Colleoni M, Sacerdote P, Trovato AE, Lonati C, Labanca M, Panerai AE, Rezzani R, Rodella LF. 2008. PPADS, a purinergic antagonist reduces Fos expression at spinal cord level in a mouse model of mononeuropathy. Brain Res 1199:74-81.
7. Chen CC, Akopian AN, Sivilotti L, Colquhoun D, Burnstock G, Wood JN. 1995. A P2X purinoceptor expressed by a subset of sensory neurons. Nature 377:428-431.
8. Dallel R, Raboisson P, Auroy P, Woda A. 1988. The rostral part of the trigeminal sensory complex is involved in orofacial nociception. Brain Res 448:7-19.
9. Dallel R, Duale C, Luccarini P, Molat JL. 1999. Stimulus-function, wind-up and modulation by diffuse noxious inhibitory controls of responses of convergent neurons of the spinal trigeminal nucleus oralis. Eur J Neurosci 11:31-40.
10. Duale C, Luccarini P, Cadet R, Woda A. 1996. Effects of morphine microinjections into the trigeminal sensory complex on the formalin test in the rat. Exp Neurol 142:331-339.
11. Franklin K, Paxinos G. 1997. The mouse brain in stereotaxic coordinates. New York: Academic Press.
12. Gordon JL. 1986. Extracellular ATP: effects, sources and fate. Biochem J 233:309-319.
13. Gourine AV, Poputnikov DM, Zhernosek N, Melenchuk EV, Gerstberger R, Spyer KM, Gourine VN. 2005. P2 receptor blockade attenuates fever and cytokine responses induced by lipopolysaccharide in rats. Br J Pharmacol 146:139-145.
14. Guan Y, Yaster M, Raja SN, Tao YX. 2007. Genetic knockout and pharmacologic inhibition of neuronal nitric oxide synthase attenuate nerve injury-induced mechanical hypersensitivity in mice. Mol Pain 3:29-38.
15. Haga KK, Gregory LJ, Hicks CA, Ward MA, Beech JS, Bath PW, Williams SC, O'Neill MJ. 2003. The neuronal nitric oxide synthase inhibitor, TRIM, as a neuroprotective agent: effects in models of cerebral ischaemia using histological and magnetic resonance imaging techniques. Brain Res 993:42-53.
16. Hamilton SG, Warburton J, Bhattacharjee A, Ward J, McMahon SB. 2000. ATP in human skin elicits a dose-related pain response which is potentiated under conditions of hyperalgesia. Brain 123:1238-1246.
17. Handy RL, Wallace P, Gaffen ZA, Whitehead KJ, Moore PK. 1995. The antinociceptive effect of 1-(2-trifluoromethylphenyl) imidazole (TRIM), a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse. Br J Pharmacol 116:2349-2350.
18. Handy RL, Harb HL, Wallace P, Gaffen Z, Whitehead KJ, Moore PK. 1996. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects. Br J Pharmacol 119:423-431.
19. He YF, Ichikawa H, Sugimoto T. 2000. The effect of neonatal capsaicin on the c-Fos-like immunoreactivity induced in subnucleus oralis neurons by noxious intraoral stimulation. Brain Res 860:203-207. (Pubitemid 30155859)
20. Inoue K. 2006. The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol Ther 109:210-226.
21. Jacquin MF, Chiaia NL, Rhoades RW. 1990. Trigeminal projections to contralateral dorsal horn: central extent, peripheral origins, and plasticity. Somatosens Mot Res 7:153-183.
22. James G, Butt AM. 2001. P2X and P2Y purinoreceptors mediate ATP-evoked calcium signalling in optic nerve glia in situ. Cell Calcium 30:251-259.
23. Jansen-Olesen I, Zhou M, Zinck T, Xu CB, Edvinsson L. 2005. Expression of inducible nitric oxide synthase in trigeminal ganglion cells during culture. Basic Clin Pharmacol Toxicol 97:355-363. (Pubitemid 43028782)
24. Jarvis MF, Burgard EC, McGaraughty S, Honore P, Lynch K, Brennan TJ, Subieta A, Van Biesen T, Cartmell J, Bianchi B, Niforatos W, Kage K, Yu H, Mikusa J, Wismer CT, Zhu CZ, Chu K, Lee CH, Stewart AO, Polakowski J, Cox BF, Kowaluk E, Williams M, Sullivan J, Faltynek C. 2002. A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Natl Acad Sci U S A 99:17179-17184.
25. Jenkins DC, Charles IG, Baylis SA, Lelchuk R, Radomski MW, Moncada S. 1994. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer 70:847-849.
26. Koganemaru M, Takasaki M, Nishimori T. 2000. Simultaneous activation of N-methyl-D-aspartate and neurokinin-1 receptors modulates c-Fos and Zif/268 expression in the rat trigeminal nucleus caudalis. Neuroscience 98:317-323.
27. Koizumi S, Fujishita K, Inoue K, Shigemoto-Mogami Y, Tsuda M, Inoue K. 2004. Ca21 waves in keratinocytes are transmitted to sensory neurons: the involvement of extracellular ATP and P2Y2 receptor activation. Biochem J 380:329-338.
28. Kolesnikov YA, Chereshnev I, Criesta M, Pan YX, Pasternak GW. 2009. Opposing actions of neuronal nitric oxide synthase isoforms in formalin-induced pain in mice. Brain Res 1289:14-21.
29. Lambrecht G. 2000. Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications. Naunyn Schmiedebergs Arch Pharmacol 362:340-350.
30. Lambrecht G, Friebe T, Grimm U, Windscheif U, Bungardt E, Hildebrandt C, Bäumert HG, Spatz-Kümbel G, Mutschler E. 1992. PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses. Eur J Pharmacol 217:217-219.
31. Luccarini P, Cadet R, Duale C, Woda A. 1998. Effects of lesions in the trigeminal oralis and caudalis subnuclei on different orofacial nociceptive responses in the rat. Brain Res 803:79-85. (Pubitemid 28392132)
32. Luccarini P, Childeric A, Gaydier AM, Voisin D, Dallel R. 2006. The orofacial formalin test in the mouse: a behavioral model for studying physiology and modulation of trigeminal nociception. J Pain 7:908-914.
33. Martucci C, Trovato AE, Costa B, Borsani E, Franchi S, Magnaghi V, Panerai AE, Rodella LF, Valsecchi AE, Sacerdote P, Colleoni M. 2008. The purinergic antagonist PPADS reduces pain related behaviours and interleukin-1beta, interleukin-6, iNOS and nNOS overproduction in central and peripheral nervous system after peripheral neuropathy in mice. Pain 137:81-95.
34. Mayer C, Quasthoff S, Grafe P. 1998. Differences in the sensitivity to purinergic stimulation of myelinating and non-myelinating Schwann cells in peripheral human and rat nerve. Glia 23:374-382.
35. McGaraughty S, Wismer CT, Zhu CZ, Mikusa J, Honore P, Chu KL, Lee C, Faltynek CR, Jarvis MF. 2003. Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration. Br J Pharmacol 140:1381-1388.
36. Mineta Y, Eisenberg E, Strassman AM. 1995. Distribution of Fos-like immunoreactivity in the caudal medullary reticular formation following noxious facial stimulation in the rat. Exp Brain Res 107:34-38.
37. Nagamatsu N, Ikeda T, Terayama R, Nakamura T, Koganemaru M, Nishimori T. 2001. Effects of previous noxious stimulus applied to remote areas on noxious stimulus-evoked c-Fos expression in the rat trigeminal nucleus caudalis. Neurosci Res 39:293-298. (Pubitemid 32186381)
38. Otahara N, Ikeda T, Sakoda S, Shiba R, Nishimori T. 2003. Involvement of NMDA receptors in Zif/268 expression in the trigeminal nucleus caudalis following formalin injection into the rat whisker pad. Brain Res Bull 62:63-70.
39. Pajot J, Pelissier T, Sierralta F, Raboisson P, Dallel R. 2000. Differential effects of trigeminal tractotomy on Adelta- and C-fiber-mediated nociceptive responses. Brain Res 863:289-292.
40. Park W, Masuda I, Cardenal-Escarcena A, Palmer DL, McCarty DJ. 1996. Inorganic pyrophosphate generation from adenosine triphosphate by cell-free human synovial fluid. J Rheumatol 23:665-671. (Pubitemid 26132851)
41. Peier AM, Moqrich A, Hergarden AC, Reeve AJ, Andersson DA, Story GM, Earley TJ, Dragoni I, McIntyre P, Bevan S, Patapoutian A. 2002. A TRP channel that senses cold stimuli and menthol. Cell 108:705-715.
42. Pickoff-Matuk JF, Rosenfeld JP, Broton JG. 1986. Lesions of the midspinal trigeminal complex are effective in producing perioral thermal hypoalgesia. Brain Res 382:291-298.
43. Puri V, Chandrala S, Puri S, Daniel CG., Klein RM, Barman NE. 2006. Ghrelin is expressed in trigeminal neurons of female mice in phase with the estrous cycle. Neuropeptides 40:35-46.
44. Queiroz G, Gebicke-Haerter PJ, Schobert A, Starke K, von Kügelgen I. 1997. Releaseof ATP from cultured rat astrocytes elicited by glutamate receptor activation. Neuroscience 78:1203-1208. (Pubitemid 27223722)
45. Rodella L, Rezzani R, Gioia M, Tredici G, Bianchi R. 1998. Expression of Fos immunoreactivity in the rat supraspinal regions following noxious visceral stimulation. Brain Res Bull 47:357-366.
46. Sessle BJ. 1987. The neurobiology of facial and dental pain: present knowledge, future directions. J Dent Res 66:962-981.
47. Shen J, Harada N, Nakazawa H, Yamashita T. 2005. Involvement of the nitric oxide-cyclic GMP pathway and neuronal nitric oxide synthase in ATP-induced Ca21 signalling in cochlear inner hair cells. Eur J Neurosci 21:2912-2922.
48. Sluyter R, Barden JA, Wiley JS. 2001. Detection of P2X purinergic receptors on human B lymphocytes. Cell Tissue Res 304:231-236. (Pubitemid 32448989)
49. Sousa AM, Prado WA. 2001. The dual effect of a nitric oxide donor in nociception. Brain Res 897:9-19.
50. Staikopoulos V, Sessle BJ, Furness JB, Jennings EA. 2007. Localization of P2X2 and P2X3 receptors in rat trigeminal ganglion neurons. Neuroscience 144:208-216.
51. Stucky CL, Medler KA, Molliver DC. 2004. The P2Y agonist UTP activates cutaneous afferent fibers. Pain 109:36-44.
52. Tsuda M, Ueno S, Inoue K. 1999. Evidence for the involvement of spinal endogenous ATP and P2X receptors in nociceptive responses caused by formalin and capsaicin in mice. Br J Pharmacol 128:1497-1504.
53. Valera S, Hussy N, Evans RJ, Adami N, North RA, Surprenant A, Buell G. 1994. A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP. Nature 371:516-519.
54. Verghese MW, Kneisler TB, Boucheron JA. 1996. P2U agonists induce chemotaxis and actin polymerization in human neutrophils and differentiated HL60 cells. J Biol Chem 271:15597-15601.
55. Watanabe M, Tanaka E, Nishi M, Iwabe T, Hattori Y, Suemune S, Tanne K. 2002. Expression of c-Fos-like immunoreactive neurons in the supratrigeminal region in the rat following noxious stimulation of the orofacial tissues. Neurosci Lett 335:99-102.
56. Watkins LR, Maier SF. 2003. Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov 2:973-985.
57. Wirkner K, Sperlagh B, Illes P. 2007. P2X3 receptor involvement in pain states. Mol Neurobiol 36:165-183. (Pubitemid 351360342)
58. Woda A, Azerad J, Albe-Fessard D. 1977. Mapping of the trigeminal sensory complex of the cat. Characterization of its neurons by stimulations of peripheral field, dental pulp afferents and thalamic projections. J Physiol (Paris) 73:367-378.
59. Zhang XF, Han P, Faltynek CR, Jarvis MF, Shieh CC. 2005. Functional expression of P2X7 receptors in non-neuronal cells of rat dorsal root ganglia. Brain Res 1052:63-70.
60. Zhao P, Barr TP, Hou Q, Dib-Hajj SD, Black JA, Albrecht PJ, Petersen K, Eisenberg E, Wymer JP, Rice FL, Waxman SG. 2008. Voltagegated sodium channel expression in rat and human epidermal keratinocytes: evidence for a role in pain. Pain 139:90-105.